We are live on
!
Find out more
CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$21B
1-Year Est. Return
21.48%
This Fund
S&P 500
This Quarter
Est. Return
+7.55%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$17.1B
AUM Growth
-$646M
(-3.6%)
Cap. Flow
-$1.62B
Cap. Flow
% of AUM
-9.46%
Top 10 Holdings %
Top 10 Hldgs %
3.13%
Holding
5,006
New
607
Increased
1,563
Reduced
1,808
Closed
822
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$62M |
| 2 |
Amazon
AMZN
|
+$53.3M |
| 3 |
CVS Health
CVS
|
+$40.3M |
| 4 |
PayPal
PYPL
|
+$34.8M |
| 5 |
McDonald's
MCD
|
+$34.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$56.8M |
| 2 |
EXE
Expand Energy Corp
EXE
|
+$43.4M |
| 3 |
Charter Communications
CHTR
|
+$42.4M |
| 4 |
Comcast
CMCSA
|
+$40.3M |
| 5 |
Mastercard
MA
|
+$37.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 12.54% |
| 2 | Technology | 11.9% |
| 3 | Consumer Discretionary | 9.76% |
| 4 | Healthcare | 8.91% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3951
American Well
AMWL
$231M
| $33.5K | ﹤0.01% |
592
+465
| +366% | +$33.5K |
|
3952
Schrodinger
SDGR
$1.4B
| $33.2K | ﹤0.01% |
1,775
-80,088
| -98% | -$1.66M |
|
|
FRC
3953
DELISTED
First Republic Bank
FRC
| $33.2K | ﹤0.01% |
272
-159,234
| -100% | -$19.4M |
|
|
ADAP
3954
DELISTED
Adaptimmune Therapeutics
ADAP
| $33K | ﹤0.01% |
+22,628
| New | +$36.6K |
|
3955
Caleres
CAL
$486M
| $32.5K | ﹤0.01% |
1,458
-13,830
| -90% | -$339K |
|
3956
Equity Lifestyle Properties
ELS
$12.5B
| $32.4K | ﹤0.01% |
502
-7,240
| -94% | -$459K |
|
3957
Oric Pharmaceuticals
ORIC
$1.41B
| $32.2K | ﹤0.01% |
5,473
-8,090
| -60% | -$27.3K |
|
3958
FirstEnergy
FE
$27.1B
| $31.7K | ﹤0.01% |
756
-61,422
| -99% | -$2.4M |
|
3959
Barnes & Noble Education
BNED
$444M
| $30.8K | ﹤0.01% |
176
-227
| -56% | -$54.1K |
|
3960
Hydrofarm Holdings
HYFM
$9.29M
| $30.2K | ﹤0.01% |
1,949
-2,797
| -59% | -$63.9K |
|
|
CTEV
3961
Claritev Corp
CTEV
$581M
| $29.7K | ﹤0.01% |
646
-3,357
| -84% | -$268K |
|
|
TRVG
3962
trivago
TRVG
$376M
| $29.7K | ﹤0.01% |
+4,393
| New | +$27K |
|
3963
PUT
Williams Companies
WMB
$87.9B
| $29.6K | ﹤0.01% |
+900
| New | +$29.3K |
|
3964
SiTime
SITM
$20.7B
| $29.2K | ﹤0.01% |
287
-93,192
| -100% | -$8.81M |
|
|
BHACW
3965
DELISTED
Focus Impact BH3 Acquisition Company Warrants
BHACW
| $29.1K | ﹤0.01% |
245,431
+10,977
| +5% | +$845 |
|
3966
Larimar Therapeutics
LRMR
$417M
| $29K | ﹤0.01% |
7,033
-23,022
| -77% | -$78.6K |
|
3967
Lineage Cell Therapeutics
LCTX
$286M
| $28.6K | ﹤0.01% |
24,477
-13,634
| -36% | -$17.2K |
|
3968
RxSight
RXST
$273M
| $27.9K | ﹤0.01% |
2,201
-3,510
| -61% | -$42.7K |
|
3969
Shattuck Labs
STTK
$682M
| $27.5K | ﹤0.01% |
11,960
-5,003
| -29% | -$12.5K |
|
3970
Cytokinetics
CYTK
$10.5B
| $27.2K | ﹤0.01% |
594
-8,896
| -94% | -$383K |
|
|
BIOSW
3971
DELISTED
BioPlus Acquisition Corp. Warrants
BIOSW
| $26.9K | ﹤0.01% |
269,683
| – | – |
|
3972
Take-Two Interactive
TTWO
$47.4B
| $26.7K | ﹤0.01% |
256
-28,541
| -99% | -$3.09M |
|
3973
ITT
ITT
$18.9B
| $26.3K | ﹤0.01% |
324
-65,275
| -100% | -$5.06M |
|
3974
NexGen Energy
NXE
$6.91B
| $26.2K | ﹤0.01% |
+5,905
| New | +$24.6K |
|
|
GTH
3975
DELISTED
Genetron Holdings Limited ADS
GTH
| $26.1K | ﹤0.01% |
+7,779
| New | +$21.4K |
|
Similar funds
GIM
ECM
JFL
BAM
SF
WIM
AIM
SIG
Cubist Systematic Strategies's Q4 2022 Portfolio in Review
As of Q4 2022, Cubist Systematic Strategies held 5,006 positions worth $17.1B, down 3.6% from $17.8B the previous quarter. Its ten largest holdings account for 3.1% of the portfolio.
Cubist Systematic Strategies withdrew a net $1.62B in Q4 2022, closing 822 positions and reducing 1,808 holdings. Its most notable exit was Edison International, an estimated $25.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 15% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Cubist Systematic Strategies opened a new position in Bristol-Myers Squibb worth $30.8M.
- Cubist Systematic Strategies's largest Q4 2022 buy was Bristol-Myers Squibb: 428,476 shares worth $30.8M.
- Cubist Systematic Strategies added most to Apple in Q4 2022, an estimated $62M increase.
- Cubist Systematic Strategies's biggest Q4 2022 reduction was Visa, cutting an estimated $56.8M.
- Cubist Systematic Strategies fully exited Edison International in Q4 2022, selling an estimated $25.2M.
- Cubist Systematic Strategies's ten largest holdings make up 3.1% of its $17.1B portfolio in Q4 2022.
- Cubist Systematic Strategies opened 607 new positions and closed 822 in Q4 2022.
- Cubist Systematic Strategies's portfolio value fell 3.6% quarter-over-quarter to $17.1B.
Based on Cubist Systematic Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.